U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07945145) titled 'A Pharmacokinetics Study of GZR33 Injection at Different Injection Sites' on Nov. 07.
Brief Summary: This trial is conducted in China. This study will be conducted to evaluate the pharmacokinetics and safety of GZR33 Injection administered at different injection sites in healthy participants.
Study Start Date: Dec. 16
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: GZR33 Injection
Administered subcutaneously (s.c.)
DRUG: GZR33 Injection
Administered subcutaneously (s.c.)
DRUG: GZR33 Injection
Administered subcutaneously (s.c.)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Gan & Lee Pharm...